Antitumor effects of MutT homolog 1 inhibitors in human bladder cancer cells

ABSTRACTAs standard second-line regimen has not been established for patients who are refractory to or relapse with cisplatin-based chemotherapy, an effective class of novel chemotherapeutic agents...